# Buspirone for Opioid Tapering

> **NCT03521960** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 18 (actual)

## Conditions studied

- Opioid-Related Disorders
- Dependency (Psychology)
- Pain, Chronic
- Opiate Withdrawal Syndrome

## Interventions

- **DRUG:** Buspirone oral capsule
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03521960
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-30
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03521960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03521960, "Buspirone for Opioid Tapering". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03521960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*